Replies to post #272200 on Avid Bioservices Inc (CDMO)

[Carboat]

The phosphatidylserine (PS) signaling pathway is a very interesting target for modulating the immune system's response to cancer. We look forward to exploring the potential of PS-targeting agents alone and with other immune modulators that may lead to novel advances in cancer therapy,

Hardly positioning PS as a breakthrough. It is interesting, they are exploring, it may. This is more early stage research. So far none of this has led to anything but dead-ends.